首页> 外国专利> Adenoviral vectors with reduced TNF response and partial E3 region deletion

Adenoviral vectors with reduced TNF response and partial E3 region deletion

机译:降低TNF反应和部分E3区缺失的腺病毒载体

摘要

Adenoviral vectors with a deletion of the E3 region such that the remaining E3 region reduces the TNF response of a host mammalian cell infected with the virus. The portion of the E3 region remaining in these vectors encodes the 14.7 kD protein, and may also contain a deletion of at least the E1a promoter. These partially deleted E3 vectors will inhibit the host cell's immune response so that the infected cell will live longer. Any non-adenoviral gene expressed from these vectors in the infected cell will be produced for a longer length of time and achieve a higher concentration than when adenoviral vectors not expressing function 14.7 kD protein are used. These 14.7 kD expressing adenoviral vectors will be useful for gene therapy and especially in cancer gene therapy where the non-adenoviral DNA sequence being expressed are preferably cytokine genes, such as IL-1, and suicide genes, such as HSV-tk. The vectors also are useful for antisense therapy.
机译:具有E3区缺失的腺病毒载体,使得剩余的E3区降低了感染了该病毒的宿主哺乳动物细胞的TNF应答。这些载体中剩余的E3区部分编码14.7 kD蛋白,并且也可能至少含有E1a启动子的缺失。这些部分缺失的E3载体将抑制宿主细胞的免疫反应,从而使被感染的细胞寿命更长。与使用不表达功能14.7 kD蛋白的腺病毒载体相比,在感染的细胞中从这些载体表达的任何非腺病毒基因将产生更长的时间并达到更高的浓度。这些表达14.7kD的腺病毒载体将用于基因治疗,尤其是在癌症基因治疗中,其中表达的非腺病毒DNA序列优选是细胞因子基因,例如IL-1,和自杀基因,例如HSV-tk。载体也可用于反义治疗。

著录项

  • 公开/公告号US6204052B1

    专利类型

  • 公开/公告日2001-03-20

    原文格式PDF

  • 申请/专利权人 INTROGENE B.V.;

    申请/专利号US19950515495

  • 申请日1995-08-15

  • 分类号C12N50/00;C12N150/00;A61K480/00;A01N630/00;

  • 国家 US

  • 入库时间 2022-08-22 01:04:51

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号